Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-05-17 @ 4:27 PM
Study NCT ID:
NCT04661150
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-21
First Post:
2020-12-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
Sponsor:
Hoffmann-La Roche
Organization: